Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating activities:
Net (loss) income	$ (3,499)	$ 437,282
Adjustments to reconcile net (loss) income to net cash used in operating activities:
Provision for doubtful accounts	0	2,759
Depreciation, amortization and accretion	2	18,417
Equity-based compensation	0	3,572
Loss (gain) on sale of operations and disposal of assets	11	(457,590)
Non-cash right-of-use ("ROU") asset lease expense	0	3,686
Non-cash interest expense	0	3,385
Settlement of cash flow hedges	0	(335)
Change in fair value of warrant liability	0	(105)
Debt extinguishment costs	0	8,527
Non-cash gain from change in fair value on cash flow hedges	0	(2,946)
Loss (gain) on forward exchange contracts and unrealized foreign exchange transactions	228	(14,789)
Deferred income taxes	0	396
Changes in operating assets and liabilities:
Accounts receivable	0	(6,460)
Equipment Installment Plan ("EIP") receivables	0	5,207
Inventory	0	(1,470)
Prepaid expenses and other current assets	12	(12,693)
Other assets	52	(1,546)
Accounts payable	(39)	(6,989)
Operating lease liabilities	0	(7,376)
Other current liabilities and accrued expenses	(6,091)	23,738
Customer deposits and unearned revenue	0	(1,866)
Net cash used in operating activities	(9,324)	(7,196)
Investing activities:
Proceeds from the sale of operations, inclusive of proceeds from forward exchange contracts of $0.1 million and $16.6 million, net of cash sold of $51.1 million	13,889	552,210
Purchase of property and equipment	0	(32,429)
Purchase of short-term investments	0	(13,837)
Other, net	0	(687)
Net cash provided by investing activities	13,889	505,257
Financing activities:
Return of capital, net of distribution repaid	(20,324)	(112,967)
Payments of debt, including sale-leaseback and EIP receivables financing obligations	0	(438,807)
Proceeds from debt	0	10,000
Proceeds from EIP receivables financing obligation	0	7,290
Other, net	0	(2,778)
Net cash used in financing activities	(20,324)	(537,262)
Net decrease in cash, cash equivalents and restricted cash	(15,759)	(39,201)
Cash, cash equivalents and restricted cash, beginning of period	25,067	55,010
Effect of exchange rate changes	0	(3,185)
Cash, cash equivalents and restricted cash, end of period	$ 9,308	$ 12,624

Trilogy International Partners Inc. 10-Q